Anti-Human DDR1 Therapeutic Antibody | 708-TAB-179MZ-S(P)

Target DDR1

Clonality Polyclonal

Target Modification Tyr513

Modification Phosphorylation

Reactivity Human, Mouse, Rat

Tested Applications ELISA, WB, IHC

Host Rabbit

Recommended dilutions WB: 1/500 - 1/3000, IHC: 1/50 - 1/100, ELISA: 1/10000. Optimal dilutions/concentrations should be determined by the end user.

Conjugation Unconjugated

Immunogen The antiserum was produced against synthesized phosphopeptide derived from human DDR1 around the

phosphorylation site of tyrosine 513 (P-A-YP-R-L).

Isotype IgG

Form Liquid

Purification Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.

Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

UniProt Primary AC Q08345 (UniProt, ExPASy)

Enzyme Commission Number EC 2.7.1.112 EC 2.7.10.1

Sequence CLLSNPAYRLLLAT

Buffer PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol.

Concentration 1 mg/ml

Availability Shipped within 5-10 working days.

Note This product is for research use only.